Exchanges
BSE, NSE
Issue
Book building

IndiaMART InterMESH IPO

₹1,301.95

+33.81% on listing

Listing-day close · NSE · 4 Jul 2019 · issue price ₹973

IndiaMART InterMESH’s ₹475 crore IPO was priced at ₹973 a share. It listed on the NSE on 4 Jul 2019 and closed its first day at ₹1,301.95, up 33.81% on the issue price.

Timeline

  1. Opens
  2. Closes
  3. Allotment
  4. Refunds
  5. Shares in demat
  6. Listing

Issue details

Issue size
₹475 Cr
Fresh issue
—
Offer for sale
₹475 Cr
Lot size
15 shares
Minimum investment
₹14,595
Face value
₹10
Registrar
MUFG Intime India

Subscription

IndiaMART InterMESH IPO subscription by investor category
CategoryShares offeredTimes subscribed
Total—20.31×

Overall, from the basis of allotment.

Financials and valuation

Market cap (post-issue)
₹2,800 Cr
Promoter holding
57.58% → 52.61%

From the offer documents.

Listing

Listing date
4 Jul 2019
Issue price
₹973
Open
₹1,180.00
High
₹1,338.00
Low
₹1,180.00
Close
₹1,301.95

Listing day on the NSE. The close was +33.81% on the issue price.

INDIAMART share price today

FAQs

When did the IndiaMART InterMESH IPO open and close?

It opened on 24 Jun 2019 and closed on 26 Jun 2019.

What was the IndiaMART InterMESH IPO price?

The price band was ₹970–973 a share. The final issue price was ₹973.

What is the lot size and minimum investment?

One lot is 15 shares, ₹14,595 at ₹973 a share. Retail investors apply in whole lots.

How much did IndiaMART InterMESH raise?

₹475 crore: ₹475 crore offered by existing shareholders.

How many times was the IndiaMART InterMESH IPO subscribed?

20.31 times overall.

How did IndiaMART InterMESH list?

It listed on the NSE on 4 Jul 2019 at ₹1,180.00 and closed the day at ₹1,301.95, up 33.81% on the ₹973 issue price.

Who is the registrar of the IndiaMART InterMESH IPO?

MUFG Intime India handles the allotment, refunds and credit of shares.

For information only. Not investment advice or a research report.

Full disclaimer

See how an IPO fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app